Growth Metrics

Dexcom (DXCM) Income from Continuing Operations (2010 - 2026)

Dexcom (DXCM) reported Income from Continuing Operations of 199500000.0 for Q1 2026, up 89.28% year-over-year from 105400000.0 in Q1 2025, and down 25.36% on a QoQ basis from 267300000.0 in Q4 2025.

Dexcom (DXCM) has 17 years of Income from Continuing Operations data on file, last reported at 199500000.0 in Q1 2026.

  • Quarterly Income from Continuing Operations rose 89.28% year-over-year to 199500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 930400000.0 (up 73.84% YoY) and the FY2025 annual result came in at 836300000.0, up 45.14% from the prior year.
  • Income from Continuing Operations eased to 199500000.0 in Q1 2026 per DXCM's latest filing, from 267300000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 283800000.0 in Q3 2025 and bottomed at 48600000.0 in Q1 2023.
  • The 5-year median for Income from Continuing Operations is 134600000.0 (2024), against an average of 146747058.82.
  • The widest annual swing landed in 2022, when Income from Continuing Operations surged 1832.08%; it then plunged 50.05% in 2023.
  • Tracing DXCM's Income from Continuing Operations over 5 years: stood at 91800000.0 in 2022, then soared by 179.19% to 256300000.0 in 2023, then plunged by 40.81% to 151700000.0 in 2024, then surged by 76.2% to 267300000.0 in 2025, then declined by 25.36% to 199500000.0 in 2026.
  • Per Business Quant, the three latest DXCM Income from Continuing Operations figures stand at 199500000.0 (Q1 2026), 267300000.0 (Q4 2025), and 283800000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 220.30 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 238.30 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 199.50 Mn
Dec 31, 2025 267.30 Mn
Sep 30, 2025 283.80 Mn
Jun 30, 2025 179.80 Mn
Mar 31, 2025 105.40 Mn
Dec 31, 2024 151.70 Mn
Sep 30, 2024 134.60 Mn
Jun 30, 2024 143.50 Mn
Mar 31, 2024 146.40 Mn
Dec 31, 2023 256.30 Mn
Sep 30, 2023 120.70 Mn
Jun 30, 2023 115.90 Mn
Mar 31, 2023 48.60 Mn
Dec 31, 2022 91.80 Mn
Sep 30, 2022 101.20 Mn
Jun 30, 2022 50.90 Mn
Mar 31, 2022 97.30 Mn
Dec 31, 2021 -5.30 Mn
Sep 30, 2021 87.30 Mn
Jun 30, 2021 78.40 Mn
Mar 31, 2021 56.50 Mn
Dec 31, 2020 411.30 Mn
Sep 30, 2020 72.20 Mn
Jun 30, 2020 46.30 Mn
Mar 31, 2020 19.90 Mn
Dec 31, 2019 92.70 Mn
Sep 30, 2019 45.80 Mn
Jun 30, 2019 -10.50 Mn
Mar 31, 2019 -26.90 Mn
Dec 31, 2018 -179.70 Mn
Sep 30, 2018 46.60 Mn
Jun 30, 2018 30.20 Mn
Mar 31, 2018 -24.20 Mn
Dec 31, 2017 -9.40 Mn
Sep 30, 2017 -2.00 Mn
Jun 30, 2017 2.90 Mn
Mar 31, 2017 -41.70 Mn
Dec 31, 2016 -7.40 Mn
Sep 30, 2016 -18.80 Mn
Jun 30, 2016 -20.20 Mn
Mar 31, 2016 -19.20 Mn
Dec 31, 2015 1.50 Mn
Sep 30, 2015 -42.50 Mn
Jun 30, 2015 -3.70 Mn
Mar 31, 2015 -12.90 Mn
Dec 31, 2014 1.40 Mn
Sep 30, 2014 -5.20 Mn
Jun 30, 2014 -6.00 Mn
Mar 31, 2014 -12.50 Mn
Dec 31, 2013 -2.60 Mn
Sep 30, 2013 -6.00 Mn
Jun 30, 2013 -10.10 Mn
Mar 31, 2013 -11.10 Mn
Dec 31, 2012 -8.50 Mn
Sep 30, 2012 -17.30 Mn
Jun 30, 2012 -14.70 Mn
Mar 31, 2012 -14.10 Mn
Dec 31, 2011 -12.21 Mn
Sep 30, 2011 -13.28 Mn
Jun 30, 2011 -7.37 Mn
Mar 31, 2011 -11.85 Mn
Dec 31, 2010 -9.83 Mn
Sep 30, 2010 -13.09 Mn
Jun 30, 2010 -11.44 Mn